Transcat, Inc.
TRNSIndustrialsNASDAQSpecialty Business Services · Last scanned Sep 7, 2026
Scan Results
Daily timeframeTranscat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. With a market capitalization of $800.1M, it sits in small-cap territory. The company operates through two segments: Service and Distribution.
Market Cap
$800.1M
Beta
0.67
P/E (TTM)
237.44
P/E (Fwd)
39.44
EPS (TTM)
$0.36
EPS (Fwd)
$2.17
ROE
1.2%
ROA
2.2%
Cash
$6.7M
Total Debt
$143.2M
Free CF
$28.0M
52W Change
7.2%
Annual Financials
Cash vs Debt
Where TRNS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, TRNS finished 4.72% above its 150-day moving average ($81.70) and 12.82% above its 200-day moving average ($75.84). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is TRNS overbought or oversold?
At the September 3, 2026 close, TRNS's RSI(14) was 27.6, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $6.7M in cash, though total debt stands at $143.2M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $28.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 1.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.2% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $205.0M (2022) to $331.9M (2026), reflecting a 62% increase over the period.
TRNS's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. At over 50x earnings, TRNS carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing TRNS.